Issue 12/2024
Content (7 Articles)
Acknowledgement to Referees
- Acknowledgement to Referees
Recent Advances in Pharmacologic Treatments of Drug-Resistant Epilepsy: Breakthrough in Sight
- Epilepsy
- Current Opinion
Pavel Klein, Daniel Friedman, Patrick Kwan
Efficacy of Cariprazine in the Psychosis Spectrum: A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials in Schizophrenia and Bipolar Disorder
- Open Access
- Cariprazine
- Systematic Review
Livio Tarchi, Susan Bugini, Cristiano Dani, Emanuele Cassioli, Eleonora Rossi, Stefano Lucarelli, Valdo Ricca, Saverio Caini, Giovanni Castellini
Early Disease-Modifying Treatments for Presymptomatic Multiple Sclerosis
- Multiple Sclerosis
- Review Article
Burcu Zeydan, Christina J. Azevedo, Naila Makhani, Mikael Cohen, Melih Tutuncu, Eric Thouvenot, Aksel Siva, Darin T. Okuda, Orhun H. Kantarci, Christine Lebrun-Frenay
Research Progress on NMDA Receptor Enhancement Drugs for the Treatment of Depressive Disorder
- Antidepressant Drugs
- Review Article
Ruyun Liu, Ning Liu, Lin Ma, Yue Liu, Zhuo Huang, Xiaodong Peng, Chunlin Zhuang, Jianguo Niu, Jianqiang Yu, Juan Du
A Multicenter, Open-Label Study to Evaluate the Long-term Safety and Efficacy of Adjunctive Brexpiprazole 2 mg Daily in Japanese Patients with Major Depressive Disorder
- Open Access
- Brexpiprazole
- Original Research Article
Masaki Kato, Masako Shiosakai, Kazuo Kuwahara, Katsuhiro Iba, Yuki Shimada, Mizuki Saito, Daisuke Sekine, Kazuo Aoki, Yuki Shiomi, Teruhiko Higuchi
Long-Term (12-Month) Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine: Data from the Phase 3 Open-Label ASCEND Study
- Open Access
- Migraine
- Original Research Article
Stewart J. Tepper, Detlef Albrecht, Jessica Ailani, Louis Kirby, Shannon Strom, Alan M. Rapoport